Standard Operating Procedure: Clinical Management of PCOS and Pregnancy

This Standard Operating Procedure (SOP) outlines the clinical protocol for managing patients with Polycystic Ovary Syndrome (PCOS) who are attempting to conceive or are currently pregnant. Due to the inherent endocrine complexities of PCOS, including increased risks of gestational diabetes, hypertension, and preterm labor, this document serves as a standardized framework to ensure patient safety, proactive monitoring, and optimized obstetric outcomes.

Phase 1: Pre-Conception Optimization

• Endocrine Evaluation: Perform a comprehensive hormonal panel (FSH, LH, Prolactin, TSH, and AMH) to assess baseline fertility status.
• Metabolic Screening: Conduct a 2-hour Oral Glucose Tolerance Test (OGTT) and HbA1c to rule out pre-existing insulin resistance or impaired glucose tolerance.
• Weight Management: Encourage a target BMI optimization through a Mediterranean-style diet and regular physical activity to improve ovulatory function.
• Medication Review: Evaluate the necessity of Metformin. If clinically indicated, continue or initiate dosage under physician supervision to manage glycemic control.
• Supplementation: Initiate Folic Acid (min. 400mcg) at least three months prior to conception to reduce the risk of neural tube defects.

Phase 2: First Trimester Monitoring

• Confirmation of Pregnancy: Perform early ultrasound (6–8 weeks) to confirm viable intrauterine pregnancy and rule out ectopic risks associated with fertility treatments.
• Early Diabetes Screening: Screen for undiagnosed Type 2 Diabetes via HbA1c in the first trimester, as PCOS patients are at higher risk.
• Thyroid Function: Monitor TSH levels, as thyroid dysfunction frequently co-occurs with PCOS and requires dose titration if TSH > 2.5 mIU/L.
• Hyperemesis Assessment: Monitor for severe morning sickness, which may be more prevalent in patients with metabolic sensitivities.

Phase 3: Second and Third Trimester Protocols

• Gestational Diabetes Mellitus (GDM) Screening: Perform the standard 50g glucose challenge test earlier than the general population (at 20–24 weeks, or earlier if symptoms arise).
• Hypertension Surveillance: Conduct bi-weekly blood pressure checks to monitor for Gestational Hypertension or Pre-eclampsia, to which PCOS patients have an elevated predisposition.
• Growth Scans: Schedule serial growth ultrasounds (typically at 28, 32, and 36 weeks) to monitor fetal weight and amniotic fluid volume.
• Lifestyle Maintenance: Maintain moderate physical activity (e.g., prenatal yoga or walking) to manage insulin resistance throughout the gestational period.

Pro Tips & Pitfalls

• Pro Tip: If the patient is using Metformin, emphasize that it does not necessarily need to be discontinued immediately upon a positive pregnancy test; consult the clinical lead for tapering protocols.
• Pro Tip: Utilize a continuous glucose monitor (CGM) if the patient shows high glycemic variability during the second trimester for better data-driven adjustments.
• Pitfall: Do not dismiss mild hypertension as "standard pregnancy bloating"; PCOS patients are statistically more vulnerable to hypertensive disorders.
• Pitfall: Avoid assuming that the absence of symptoms means a lack of metabolic risk. Always adhere to the established screening schedule regardless of the patient's physical appearance.

Frequently Asked Questions

Q: Does Metformin cause birth defects? A: Current clinical data suggests Metformin is safe during pregnancy; however, it should always be prescribed and managed under the strict guidance of an obstetrician or endocrinologist.

Q: Are PCOS patients guaranteed to develop Gestational Diabetes? A: No. While the risk is significantly higher than in the general population, maintaining a balanced diet, consistent exercise, and appropriate medical surveillance can effectively mitigate the risk.

Q: Should I continue my fertility treatments after getting pregnant? A: Once a viable pregnancy is confirmed, fertility-specific drugs (like Clomid or Letrozole) are typically discontinued. All medication changes must be directed by your fertility specialist during the transition to routine prenatal care.